ATE447416T1 - Kontrastmittelformulierungen mit verbesserter biologischer verträglichkeit - Google Patents

Kontrastmittelformulierungen mit verbesserter biologischer verträglichkeit

Info

Publication number
ATE447416T1
ATE447416T1 AT03786628T AT03786628T ATE447416T1 AT E447416 T1 ATE447416 T1 AT E447416T1 AT 03786628 T AT03786628 T AT 03786628T AT 03786628 T AT03786628 T AT 03786628T AT E447416 T1 ATE447416 T1 AT E447416T1
Authority
AT
Austria
Prior art keywords
contrast agent
improved biological
agent formulations
formulations
biological tolerability
Prior art date
Application number
AT03786628T
Other languages
English (en)
Inventor
Milos Sovak
Allen Seligson
Ronald C Terry
Original Assignee
Biophysica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biophysica Inc filed Critical Biophysica Inc
Application granted granted Critical
Publication of ATE447416T1 publication Critical patent/ATE447416T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
AT03786628T 2002-12-12 2003-11-07 Kontrastmittelformulierungen mit verbesserter biologischer verträglichkeit ATE447416T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43287902P 2002-12-12 2002-12-12
US10/701,586 US7250153B2 (en) 2002-12-12 2003-11-05 Contrast media formulations having improved biological tolerance
PCT/US2003/035762 WO2004054637A2 (en) 2002-12-12 2003-11-07 Contrast media formulations having improved biological tolerance

Publications (1)

Publication Number Publication Date
ATE447416T1 true ATE447416T1 (de) 2009-11-15

Family

ID=34107426

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03786628T ATE447416T1 (de) 2002-12-12 2003-11-07 Kontrastmittelformulierungen mit verbesserter biologischer verträglichkeit

Country Status (18)

Country Link
US (1) US7250153B2 (de)
EP (1) EP1575621B1 (de)
JP (1) JP2006509841A (de)
KR (1) KR101067159B1 (de)
CN (1) CN1738651A (de)
AT (1) ATE447416T1 (de)
AU (1) AU2003295442B2 (de)
CA (1) CA2509035C (de)
CY (1) CY1110105T1 (de)
DE (1) DE60329939D1 (de)
DK (1) DK1575621T3 (de)
ES (1) ES2333863T3 (de)
IL (1) IL169119A (de)
NO (1) NO332350B1 (de)
NZ (1) NZ541139A (de)
PT (1) PT1575621E (de)
SI (1) SI1575621T1 (de)
WO (1) WO2004054637A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2253332B1 (de) * 2004-03-11 2012-10-10 Mallinckrodt LLC Röntgenkontrastformulierung mit geringer Osmolarität
FR2899581B1 (fr) * 2006-04-07 2008-06-27 Guerbet Sa Procede d'atomisation du ioxilan
ES2391002T3 (es) 2008-01-14 2012-11-20 Mallinckrodt Llc Proceso para la preparación de iosimenol
EP2550022B1 (de) * 2010-03-23 2020-12-09 GE Healthcare AS Herstellung von stabilisierten diagnostischen röntgenkontrastmittel-zusammensetzungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4278654A (en) * 1978-07-04 1981-07-14 Nyegaard & Co. A/S Process for the preparation of a sterile injectable physiologically acceptable solution of an X-ray contrast agent and solutions of the X-ray contrast agent and a buffer
US5698739A (en) * 1989-07-05 1997-12-16 Schering Aktiengesellschaft Carboxamide non-ionic contrast media
AU6114396A (en) * 1995-06-16 1997-01-15 Biophysica Foundation Formyl derivatives as nonionic contrast media
DE19648650C2 (de) 1996-01-29 1998-07-02 Schering Ag Puffersysteme und deren Verwendung zur Stabilisierung pharmazeutischer Zubereitung

Also Published As

Publication number Publication date
NO20053343L (no) 2005-09-08
SI1575621T1 (sl) 2010-01-29
PT1575621E (pt) 2009-11-13
EP1575621B1 (de) 2009-11-04
CY1110105T1 (el) 2015-01-14
CA2509035C (en) 2011-07-19
NZ541139A (en) 2008-07-31
EP1575621A4 (de) 2008-11-26
DE60329939D1 (de) 2009-12-17
US7250153B2 (en) 2007-07-31
CN1738651A (zh) 2006-02-22
ES2333863T3 (es) 2010-03-02
AU2003295442B2 (en) 2008-11-06
NO20053343D0 (no) 2005-07-08
IL169119A (en) 2010-06-16
IL169119A0 (en) 2007-07-04
DK1575621T3 (da) 2009-12-14
US20050025711A1 (en) 2005-02-03
WO2004054637A3 (en) 2004-09-16
WO2004054637A2 (en) 2004-07-01
KR101067159B1 (ko) 2011-09-22
CA2509035A1 (en) 2004-07-01
AU2003295442A1 (en) 2004-07-09
JP2006509841A (ja) 2006-03-23
NO332350B1 (no) 2012-09-03
EP1575621A2 (de) 2005-09-21
KR20050088312A (ko) 2005-09-05

Similar Documents

Publication Publication Date Title
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
CY1119742T1 (el) Βιολογικα συστηματα μεταφορας πολλαπλου-συστατικου
CY1111844T1 (el) Angiopep-1, σχετικες ενωσεις, και χρησεις αυτων
BRPI0519047A2 (pt) mÉtodo para a produÇço de um agente de contraste marcador ou agente terapÊutico marcador, agentes de contraste marcadores e uso de agentes de contraste marcadores ou de agentes terapÊuticos marcadores
ECSP077401A (es) Medicamentos que contienen compuestos de carbonilo y su uso
MXPA04008068A (es) Metodo para administrar moleculas de glp-1.
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
WO2003061593A3 (en) Novel targeted compositions for diagnostic and therapeutic use
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
DK1472344T3 (da) Bakteriofaglysin
CY1110105T1 (el) Σκευασματα σκιαγραφικων μεσων που εχουν βελτιωμενη ανεκτικοτητα
ATE326968T1 (de) Pharmazeutische zusammensetzung enthaltend tenatoprazol und einen entzündungshemmer
DK1713438T3 (da) Medicinsk sæbe
CY1107158T1 (el) Νεα παραγωγα της ισοκινολινης, η μεθοδος παρασκευης τους και η χρηση τους για τη θεραπεια των διαταραχων του μελατονινεργικου συστηματος
CY1109657T1 (el) Φαρμακευτικες συνθεσεις ηρεμιστικου υπνωτικου μεσου ταχειας δρασης
DE60041198D1 (de) Antimikrobielle zusammensetzungen
CY1114113T1 (el) Συνδυασμος ενος αναστολεα του κολπικου ρευματος if και ενος βητα-αναστολεα
UA87291C2 (ru) Пероральное пленкообразное лекарственное средство дезоксипеганина и способ его применения
EP1281887A3 (de) Rundlager
TH87788A (th) สูตรยาที่มีการปล่อยคงที่และการใช้ของสิ่งนั้น
GT200300260A (es) Derivados de anilinopirazol utiles en el tratamiento de la diabetes
TH92464A (th) สารประกอบ
ITRM20030440A0 (it) Sistema d'indicazione temporale, in particolare dell'orario.
UA27412U (en) Albuminous surgical adhesive
TH94287A (th) ตัวยับยั้งเฮเทโรไซคลิก cetp

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1575621

Country of ref document: EP